Header Logo

Connection

MARIE-CLAUDE HOFMANN to Humans

Back to Details
This is a "connection" page, showing publications MARIE-CLAUDE HOFMANN has written about Humans.
MARIE-CLAUDE HOFMANN
Connection Strength
0.204
Humans
  1. Molecular mechanisms of resistance to kinase inhibitors and redifferentiation in thyroid cancers. Endocr Relat Cancer. 2022 11 01; 29(11):R173-R190.
    View in: PubMed
    Score: 0.017
  2. Sertoli Cell-Germ Cell Interactions Within the Niche: Paracrine and Juxtacrine Molecular Communications. Front Endocrinol (Lausanne). 2022; 13:897062.
    View in: PubMed
    Score: 0.017
  3. Andrology Awards 2019 and 2020. Andrology. 2021 07; 9(4):1025-1026.
    View in: PubMed
    Score: 0.016
  4. Acquired Secondary RAS Mutation in BRAFV600E-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors. Thyroid. 2020 09; 30(9):1288-1296.
    View in: PubMed
    Score: 0.015
  5. The COVID-19 pandemics: Shall we expect andrological consequences? A call for contributions to ANDROLOGY. Andrology. 2020 05; 8(3):528-529.
    View in: PubMed
    Score: 0.015
  6. Regulation of GDNF expression in Sertoli cells. Reproduction. 2019 03; 157(3):R95-R107.
    View in: PubMed
    Score: 0.013
  7. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells. Neoplasia. 2018 11; 20(11):1121-1134.
    View in: PubMed
    Score: 0.013
  8. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model. Oncotarget. 2016 May 24; 7(21):30907-23.
    View in: PubMed
    Score: 0.011
  9. Thyroid C-Cell Biology and Oncogenic Transformation. Recent Results Cancer Res. 2015; 204:1-39.
    View in: PubMed
    Score: 0.010
  10. Stem cells and nanomaterials. Adv Exp Med Biol. 2014; 811:255-75.
    View in: PubMed
    Score: 0.009
  11. NOTCH signaling in Sertoli cells regulates gonocyte fate. Cell Cycle. 2013 Aug 15; 12(16):2538-45.
    View in: PubMed
    Score: 0.009
  12. Signaling pathways in spermatogonial stem cells and their disruption by toxicants. Birth Defects Res C Embryo Today. 2009 Mar; 87(1):35-42.
    View in: PubMed
    Score: 0.007
  13. Gdnf signaling pathways within the mammalian spermatogonial stem cell niche. Mol Cell Endocrinol. 2008 Jun 25; 288(1-2):95-103.
    View in: PubMed
    Score: 0.006
  14. Fibronectin Contributes to a BRAF Inhibitor-driven Invasive Phenotype in Thyroid Cancer through EGR1, Which Can Be Blocked by Inhibition of ERK1/2. Mol Cancer Res. 2023 09 01; 21(9):867-880.
    View in: PubMed
    Score: 0.005
  15. Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance. Front Endocrinol (Lausanne). 2023; 14:1176731.
    View in: PubMed
    Score: 0.005
  16. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAFV600E Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid. 2023 04; 33(4):484-491.
    View in: PubMed
    Score: 0.004
  17. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology. Hum Reprod. 2022 10 31; 37(11):2497-2502.
    View in: PubMed
    Score: 0.004
  18. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.
    View in: PubMed
    Score: 0.004
  19. A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab. 2021 09 27; 106(10):2962-2978.
    View in: PubMed
    Score: 0.004
  20. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid. 2021 08; 31(8):1235-1243.
    View in: PubMed
    Score: 0.004
  21. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. 2020 09 01; 6(9):1397-1404.
    View in: PubMed
    Score: 0.004
  22. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid. 2018 07; 28(7):945-951.
    View in: PubMed
    Score: 0.003
  23. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res. 2015 Oct 01; 75(19):4131-42.
    View in: PubMed
    Score: 0.003
  24. Cell-laden hydrogels in integrated microfluidic devices for long-term cell culture and tubulogenesis assays. Small. 2013 Sep 23; 9(18):3076-81.
    View in: PubMed
    Score: 0.002
  25. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab. 2013 Apr; 98(4):1492-7.
    View in: PubMed
    Score: 0.002
  26. Stem cell potential of the mammalian gonad. Front Biosci (Elite Ed). 2009 06 01; 1(2):510-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.